About Nevoa

Nevoa was founded to innovate new disinfection products that save lives, reduce pain and suffering, and instill confidence and peace of mind for every person in environments where germs and pathogens are known to thrive.

1.7 million Americans suffer from contracting an HAI annually, spending between 3 to 23 extra days hospitalized. About 100,000 of these Americans die, making HAIs the 4th leading cause of death in the US.

HAIs cost between $35 billion and $45 billion for acute-care hospitals annually. The total direct, indirect and nonmedical costs of HAIs are estimated between $96 billion to $147 billion annually, including loss of work, legal costs, increased insurance premiums and more.


Introducing Microburst
Utilizing The Patented KarmaCap

•  Pathogen Elimination Solution

•  Hypochlorous Acid Formulation

•  EPA Registered

•  Unique Mixing Cap Eliminates Shelf Life Constraints

•  H2O By-product

Nimbus™ is designed specifically to be so fast and simple it is used every time before a new patient checks in – and again when a surgery patient leaves the room for pre-op prepping. This means less manual cleaning time and the assurance of EPA Registration that ALL of the surfaces in the room are completely disinfected.

The Nimbus + Microburst™ System atomizes a unique, environmentally safe disinfectant type (H2O is the by-product) that occurs naturally in the human body to kill invasive organisms and fight infection. This hypochlorous acid solution (HOCl) is activated, then removed from the room in 3 easy steps and in less time than a typical terminal cleaning – and results in a higher level of efficacy.

Learn more at https://www.nevoainc.com.


 KarmaCap Technology

©2014 Karma Culture LLC. All rights reserved.